CUSIP: 53630X104
Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,903,096
-
Share change
-
-35,022
-
Total reported value
-
$9,535,000
-
Put/Call ratio
-
6.8%
-
Price per share
-
$0.80
-
Number of holders
-
42
-
Value change
-
-$551,236
-
Number of buys
-
17
-
Number of sells
-
16
Quarterly Holders Quick Answers
What is CUSIP 53630X104?
CUSIP 53630X104 identifies LPCN - LIPOCINE INC NEW - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2022
-
Previous quarter:
Q1 2022
Recent filing periods for CUSIP 53630X104:
Institutional Holders of LIPOCINE INC NEW - COM (LPCN) as of Q2 2022
As of 30 Jun 2022,
LIPOCINE INC NEW - COM (LPCN) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,903,096 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., WEALTH EFFECTS LLC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, MARSHALL WACE, LLP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, STATE STREET CORP, TWO SIGMA ADVISERS, LP, and MERCER GLOBAL ADVISORS INC /ADV.
This page lists
42
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.